Progression of whole blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in patients with severe influenza

[1]  L. Kobzik,et al.  Influenza lung injury: mechanisms and therapeutic opportunities. , 2015, American journal of physiology. Lung cellular and molecular physiology.

[2]  Richard J. Miller,et al.  Neutrophil trails guide influenza-specific CD8+ T cells in the airways , 2015, Science.

[3]  A. Sher,et al.  Type I interferons in infectious disease , 2015, Nature Reviews Immunology.

[4]  Paul Kellam,et al.  Accumulation of Human-Adapting Mutations during Circulation of A(H1N1)pdm09 Influenza Virus in Humans in the United Kingdom , 2014, Journal of Virology.

[5]  E. Boritz,et al.  Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression , 2014, Nature.

[6]  A. Sher,et al.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk , 2014, Nature.

[7]  A. O’Garra,et al.  The application of transcriptional blood signatures to enhance our understanding of the host response to infection: the example of tuberculosis , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[8]  Sophia Davidson,et al.  Pathogenic potential of interferon αβ in acute influenza infection , 2014, Nature Communications.

[9]  Anne M Johnson,et al.  Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study , 2014, The Lancet Respiratory Medicine.

[10]  M. Ranieri,et al.  A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection , 2013, Influenza and other respiratory viruses.

[11]  C. Chiu,et al.  Protective and dysregulated T cell immunity in RSV infection , 2013, Current opinion in virology.

[12]  E. Walsh,et al.  Bacterial Complications of Respiratory Tract Viral Illness: A Comprehensive Evaluation , 2013, The Journal of infectious diseases.

[13]  Kelly Domico,et al.  Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. , 2013, Immunity.

[14]  S. Dudman,et al.  Within-patient emergence of the influenza A(H1N1)pdm09 HA1 222G variant and clear association with severe disease, Norway. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  L. Carin,et al.  A Host Transcriptional Signature for Presymptomatic Detection of Infection in Humans Exposed to Influenza H1N1 or H3N2 , 2013, PloS one.

[16]  P. Horby,et al.  Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. , 2012, The Lancet. Infectious diseases.

[17]  Chien-Chang Lee,et al.  Can procalcitonin tests aid in identifying bacterial infections associated with influenza pneumonia? A systematic review and meta‐analysis , 2012, Influenza and other respiratory viruses.

[18]  Paul Kellam,et al.  IFITM3 restricts the morbidity and mortality associated with influenza , 2012, Nature.

[19]  O. Ramilo,et al.  Plasticity and Virus Specificity of the Airway Epithelial Cell Immune Response during Respiratory Virus Infection , 2012, Journal of Virology.

[20]  Michael G. Katze,et al.  Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.

[21]  M. Tate,et al.  Neutrophils sustain effective CD8+ T‐cell responses in the respiratory tract following influenza infection , 2012, Immunology and cell biology.

[22]  Eva K. Lee,et al.  Systems Biology of Seasonal Influenza Vaccination in Humans , 2011, Nature Immunology.

[23]  N. Van Rooijen,et al.  Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis , 2011, The American Journal of Pathology.

[24]  W. Lim,et al.  Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009) , 2010, Thorax.

[25]  Michael Shaw,et al.  Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. , 2010, The New England journal of medicine.

[26]  D. Hui,et al.  Clinical Management of Pandemic 2009 Influenza A(H1N1) Infection , 2010, Chest.

[27]  V. Pascual,et al.  A genomic approach to human autoimmune diseases. , 2010, Annual review of immunology.

[28]  A. Osterhaus,et al.  Introduction of Virulence Markers in PB2 of Pandemic Swine-Origin Influenza Virus Does Not Result in Enhanced Virulence or Transmission , 2010, Journal of Virology.

[29]  J. Rossen,et al.  A Systemic Neutrophil Response Precedes Robust CD8+ T-Cell Activation during Natural Respiratory Syncytial Virus Infection in Infants , 2009, Journal of Virology.

[30]  J. Peiris,et al.  Innate immune responses to influenza A H5N1: friend or foe? , 2009, Trends in immunology.

[31]  Damien Chaussabel,et al.  Genomic transcriptional profiling identifies a candidate blood biomarker signature for the diagnosis of septicemic melioidosis , 2009, Genome Biology.

[32]  L. Carin,et al.  Gene expression signatures diagnose influenza and other symptomatic respiratory viral infections in humans. , 2009, Cell host & microbe.

[33]  S. Coughlan,et al.  Development of a real-time RT-PCR for the detection of Swine-lineage Influenza A (H1N1) virus infections , 2009, Journal of Clinical Virology.

[34]  Virginia Pascual,et al.  A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. , 2008, Immunity.

[35]  J. Banchereau,et al.  Gene expression patterns in blood leukocytes discriminate patients with acute infections. , 2007, Blood.

[36]  J. Marshall.  Iatrogenesis, inflammation and organ injury: insights from a murine model , 2006, Critical care.

[37]  Yi Guan,et al.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.

[38]  France Gauvin,et al.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[39]  K. Stöhr.  Preventing and treating influenza , 2003, BMJ : British Medical Journal.

[40]  C. Biron.  Interferons α and β as Immune Regulators—A New Look , 2001 .

[41]  T. Kuiken,et al.  Pathogenesis of influenza-induced acute respiratory distress syndrome. , 2014, The Lancet. Infectious diseases.

[42]  C. Biron.  Interferons alpha and beta as immune regulators--a new look. , 2001, Immunity.

[43]  M. Ashburner,et al.  The Gene Ontology Consortium , 2000 .

[44]  Sandra Romero-Steiner,et al.  Molecular signatures of antibody responses derived from a systems biology study of five human vaccines , 2022 .